Literature DB >> 14634223

Isolation and culture of prostate cancer cell lines.

Nora M Navone1, Matilde Olive, Patricia Troncoso.   

Abstract

Entities:  

Mesh：

Year:  2004        PMID： 14634223     DOI： 10.1385/1-59259-406-9:121

Source DB:  PubMed          Journal:  Methods Mol Med        ISSN： 1543-1894


× No keyword cloud information.
  4 in total

1.  Differentially methylated genes and androgen receptor re-expression in small cell prostate carcinomas.

Authors:  Brittany Kleb; Marcos R H Estécio; Jiexin Zhang; Vassiliki Tzelepi; Woonbok Chung; Jaroslav Jelinek; Nora M Navone; Salahaldin Tahir; Victor E Marquez; Jean-Pierre Issa; Sankar Maity; Ana Aparicio
Journal:  Epigenetics       Date:  2016-02-18       Impact factor: 4.528

2.  The MD Anderson Prostate Cancer Patient-derived Xenograft Series (MDA PCa PDX) Captures the Molecular Landscape of Prostate Cancer and Facilitates Marker-driven Therapy Development.

Authors:  Nallasivam Palanisamy; Jun Yang; Peter D A Shepherd; Elsa M Li-Ning-Tapia; Estefania Labanca; Ganiraju C Manyam; Murali K Ravoori; Vikas Kundra; John C Araujo; Eleni Efstathiou; Louis L Pisters; Xinhai Wan; Xuemei Wang; Elba S Vazquez; Ana M Aparicio; Shannon L Carskadon; Scott A Tomlins; Lakshmi P Kunju; Arul M Chinnaiyan; Bradley M Broom; Christopher J Logothetis; Patricia Troncoso; Nora M Navone
Journal:  Clin Cancer Res       Date:  2020-06-23       Impact factor: 12.531

3.  Effects of urinary extracellular vesicles from prostate cancer patients on the transcriptomes of cancer-associated and normal fibroblasts.

Authors:  Lilite Sadovska; Pawel Zayakin; Cristina Bajo-Santos; Edgars Endzeliņš; Jānis Auders; Laura Keiša; Juris Jansons; Vilnis Lietuvietis; Aija Linē
Journal:  BMC Cancer       Date:  2022-10-12       Impact factor: 4.638

4.  Role of Testosterone Levels on the Combinatorial Effect of Boswellia serrata Extract and Enzalutamide on Androgen Dependent LNCaP Cells and in Patient Derived Cells.

Authors:  Prathesha Pillai; Ginil Kumar Pooleri; Shantikumar V Nair
Journal:  Integr Cancer Ther       Date:  2021 Jan-Dec       Impact factor: 3.279
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.